Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research

Table 2

Body mass index and comorbidity rates of our study compared with ASIAN-HF Registry, JASPER, TOPCAT, and I-PRESERVE trials.

Variables	Our	ASIAN-HF	JASPER	TOPCAT	I-PRESERVE
N	477	1204	535	3445	4133
BMI (Kg/m^2)	22.8	27.1	23.9	32	30
History
CAD (%)	50.7	29.5	27.7	59	48
HTN (%)	68.6	71.2	77.2	91	88
AF (%)	38.8	28.6	61.5	35	29
Non-CV comorbidities
Dyslipidemia (%)	54.3	—	42.2	60	44
DM (%)	26.6	45	38.1	32	28
CKD (%)	21.6	50.2	50.8	39	31

CAD: coronary artery disease; HTN: hypertension; AF: atrial fibrillation/flutter; DM: diabetes mellitus; CKD: chronic kidney disease; BMI: body mass index.